{
    "PMC8668943_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "copy number": "1",
                        "OR": "0.29",
                        "CI": "0.12-0.71",
                        "P-value": "0.007",
                        "PBonf": "0.464",
                        "adjusted OR": "0.37",
                        "adjusted P-value": "0.029"
                    },
                    "measures": "[HIV-1 acquisition, reduced odds]",
                    "outcomes": [
                        "[birthweight, controlled for]",
                        "[FCGR2C genotypes, controlled for]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Effect of FCGR2C CNR1 copy number distribution on perinatal HIV-1 acquisition",
                        "adjustment factors": "birthweight and FCGR2C genotypes",
                        "group": "Total group",
                        "Fc\u03b3RIIc copy number": "1 copy",
                        "Bonferroni corrected P-value": "0.112"
                    },
                    "measures": "[Univariate OR, 95% CI, P-value]",
                    "outcomes": "[0.29, (0.12-0.71), 0.007]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "copy number": "1",
                        "OR": "0.29",
                        "CI": "0.12-0.71",
                        "P-value": "0.007",
                        "PBonf": "0.464",
                        "adjusted OR": "0.37",
                        "adjusted P-value": "0.029"
                    },
                    "measures": "[HIV-1 acquisition, reduced odds]",
                    "outcomes": [
                        "[birthweight, controlled for]",
                        "[FCGR2C genotypes, controlled for]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Effect of FCGR2C CNR1 copy number distribution on perinatal HIV-1 acquisition",
                        "adjustment factors": "birthweight and FCGR2C genotypes",
                        "group": "Total group",
                        "Fc\u03b3RIIc copy number": "1 copy",
                        "Bonferroni corrected P-value": "0.464"
                    },
                    "measures": "[Adjusted OR, 95%CI, P-value]",
                    "outcomes": "[0.37 (0.15-0.90), 0.029]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "copy number": "2",
                        "OR": "Ref",
                        "CI": "-",
                        "P-value": "-",
                        "PBonf": "-",
                        "adjusted OR": "Ref",
                        "adjusted P-value": "-"
                    },
                    "measures": "[HIV-1 acquisition, reference]",
                    "outcomes": [
                        "[birthweight, not controlled for]",
                        "[FCGR2C genotypes, not controlled for]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Effect of FCGR2C CNR1 copy number distribution on perinatal HIV-1 acquisition",
                        "adjustment factors": "birthweight and FCGR2C genotypes",
                        "group": "Total group",
                        "Fc\u03b3RIIc copy number": "1 copy",
                        "Bonferroni corrected P-value": "0.112"
                    },
                    "measures": "[Univariate OR, 95% CI, P-value]",
                    "outcomes": "[0.29, (0.12-0.71), 0.007]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "copy number": "2",
                        "OR": "Ref",
                        "CI": "-",
                        "P-value": "-",
                        "PBonf": "-",
                        "adjusted OR": "Ref",
                        "adjusted P-value": "-"
                    },
                    "measures": "[HIV-1 acquisition, reference]",
                    "outcomes": [
                        "[birthweight, not controlled for]",
                        "[FCGR2C genotypes, not controlled for]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Effect of FCGR2C CNR1 copy number distribution on perinatal HIV-1 acquisition",
                        "adjustment factors": "birthweight and FCGR2C genotypes",
                        "group": "Total group",
                        "Fc\u03b3RIIc copy number": "2 copies",
                        "statistical measure": "Adjusted OR",
                        "value": "Ref"
                    }
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "copy number": "\u22653",
                        "OR": "0.99",
                        "CI": "0.63-1.57",
                        "P-value": "0.978",
                        "PBonf": "-",
                        "adjusted OR": "0.74",
                        "adjusted P-value": "0.275"
                    },
                    "measures": "[HIV-1 acquisition, no association]",
                    "outcomes": [
                        "[birthweight, not controlled for]",
                        "[FCGR2C genotypes, not controlled for]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Effect of FCGR2C CNR1 copy number distribution on perinatal HIV-1 acquisition",
                        "adjustment factors": "birthweight and FCGR2C genotypes",
                        "group": "Total group",
                        "Fc\u03b3RIIc copy number": "1 copy",
                        "Bonferroni corrected P-value": "0.112"
                    },
                    "measures": "[Univariate OR, 95% CI, P-value]",
                    "outcomes": "[0.29, (0.12-0.71), 0.007]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "copy number": "\u22653",
                        "OR": "0.99",
                        "CI": "0.63-1.57",
                        "P-value": "0.978",
                        "PBonf": "-",
                        "adjusted OR": "0.74",
                        "adjusted P-value": "0.275"
                    },
                    "measures": "[HIV-1 acquisition, no association]",
                    "outcomes": [
                        "[birthweight, not controlled for]",
                        "[FCGR2C genotypes, not controlled for]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Effect of FCGR2C CNR1 copy number distribution on perinatal HIV-1 acquisition",
                        "adjustment factors": "birthweight and FCGR2C genotypes",
                        "group": "Total group",
                        "Fc\u03b3RIIc copy number": "\u22653 copies"
                    },
                    "measures": "[Univariate OR, 95% CI, P-value]",
                    "outcomes": "[0.99, (0.63-1.57), 0.978]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "copy number": "\u22653",
                        "OR": "0.99",
                        "CI": "0.63-1.57",
                        "P-value": "0.978",
                        "PBonf": "-",
                        "adjusted OR": "0.74",
                        "adjusted P-value": "0.275"
                    },
                    "measures": "[HIV-1 acquisition, no association]",
                    "outcomes": [
                        "[birthweight, not controlled for]",
                        "[FCGR2C genotypes, not controlled for]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Effect of FCGR2C CNR1 copy number distribution on perinatal HIV-1 acquisition",
                        "adjustment factors": "birthweight and FCGR2C genotypes",
                        "group": "Total group",
                        "Fc\u03b3RIIc copy number": "\u22653 copies"
                    },
                    "measures": "[Adjusted OR, 95% CI, P-value]",
                    "outcomes": "[0.74, (0.43-1.27), 0.275]"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 3,
        "total_ground_truth_claims": 5,
        "number_of_matches": 2
    },
    "PMC5817808_2": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive breast feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "1.35 [0.52-3.49]",
                        "0.54"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive breast feeding"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "1.16 [0.44-3.08]",
                        "0.76"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive replacement feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive replacement feeding"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Mixed feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.31 [0.04-2.42]",
                        "0.26"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Mixed feeding"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.44 [0.053-3.74]",
                        "0.45"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Positive"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.31 [0.11-0.90]",
                        "0.032"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Positive"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.30 [0.08-1.11]",
                        "0.071"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Negative"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Negative"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "Birth weight": ">= 2500 g"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.70 [0.16-2.96]",
                        "0.63"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "Birth weight": ">= 2500 g"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.93 [0.21-4.12]",
                        "0.92"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "Birth weight": "< 2500 g"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "Birth weight": "< 2500 g"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study population": "2.58%",
                        "feeding option": "MF",
                        "p-value": "0.032"
                    },
                    "measures": "[study population, mortality]",
                    "outcomes": "[feeding option, mortality]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Global Schoenfeld residuals test",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program"
                    },
                    "measures": [
                        "p-value"
                    ],
                    "outcomes": [
                        "0.23"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "mode of feeding": "Exclusive breast feeding",
                        "unadjusted HR": "1.35",
                        "p-value": "0.76",
                        "adjusted HR": "1.16"
                    },
                    "measures": "[mode of feeding, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive breast feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "1.35 [0.52-3.49]",
                        "0.54"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "mode of feeding": "Exclusive breast feeding",
                        "unadjusted HR": "1.35",
                        "p-value": "0.76",
                        "adjusted HR": "1.16"
                    },
                    "measures": "[mode of feeding, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive breast feeding"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "1.16 [0.44-3.08]",
                        "0.76"
                    ]
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "mode of feeding": "Mixed feeding",
                        "unadjusted HR": "0.31",
                        "p-value": "0.45",
                        "adjusted HR": "0.44"
                    },
                    "measures": "[mode of feeding, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive breast feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "1.35 [0.52-3.49]",
                        "0.54"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "mode of feeding": "Mixed feeding",
                        "unadjusted HR": "0.31",
                        "p-value": "0.45",
                        "adjusted HR": "0.44"
                    },
                    "measures": "[mode of feeding, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive replacement feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "mode of feeding": "Mixed feeding",
                        "unadjusted HR": "0.31",
                        "p-value": "0.45",
                        "adjusted HR": "0.44"
                    },
                    "measures": "[mode of feeding, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive replacement feeding"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "mode of feeding": "Mixed feeding",
                        "unadjusted HR": "0.31",
                        "p-value": "0.45",
                        "adjusted HR": "0.44"
                    },
                    "measures": "[mode of feeding, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Mixed feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.31 [0.04-2.42]",
                        "0.26"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "mode of feeding": "Mixed feeding",
                        "unadjusted HR": "0.31",
                        "p-value": "0.45",
                        "adjusted HR": "0.44"
                    },
                    "measures": "[mode of feeding, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Mixed feeding"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.44 [0.053-3.74]",
                        "0.45"
                    ]
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "mode of feeding": "Exclusive replacement feeding",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[mode of feeding, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive breast feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "1.35 [0.52-3.49]",
                        "0.54"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "mode of feeding": "Exclusive replacement feeding",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[mode of feeding, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive replacement feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV- Status": "Positive",
                        "unadjusted HR": "0.31",
                        "p-value": "0.071",
                        "adjusted HR": "0.30"
                    },
                    "measures": "[HIV- Status, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive breast feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "1.35 [0.52-3.49]",
                        "0.54"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV- Status": "Positive",
                        "unadjusted HR": "0.31",
                        "p-value": "0.071",
                        "adjusted HR": "0.30"
                    },
                    "measures": "[HIV- Status, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive replacement feeding"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV- Status": "Positive",
                        "unadjusted HR": "0.31",
                        "p-value": "0.071",
                        "adjusted HR": "0.30"
                    },
                    "measures": "[HIV- Status, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Mixed feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.31 [0.04-2.42]",
                        "0.26"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV- Status": "Positive",
                        "unadjusted HR": "0.31",
                        "p-value": "0.071",
                        "adjusted HR": "0.30"
                    },
                    "measures": "[HIV- Status, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Positive"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.31 [0.11-0.90]",
                        "0.032"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV- Status": "Positive",
                        "unadjusted HR": "0.31",
                        "p-value": "0.071",
                        "adjusted HR": "0.30"
                    },
                    "measures": "[HIV- Status, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Positive"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.30 [0.08-1.11]",
                        "0.071"
                    ]
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV- Status": "Negative",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[HIV- Status, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive breast feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "1.35 [0.52-3.49]",
                        "0.54"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV- Status": "Negative",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[HIV- Status, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive replacement feeding"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV- Status": "Negative",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[HIV- Status, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Mixed feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.31 [0.04-2.42]",
                        "0.26"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV- Status": "Negative",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[HIV- Status, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Positive"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.31 [0.11-0.90]",
                        "0.032"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV- Status": "Negative",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[HIV- Status, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Negative"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": ">=2500 g",
                        "unadjusted HR": "0.88",
                        "p-value": "0.92",
                        "adjusted HR": "0.93"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive breast feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "1.35 [0.52-3.49]",
                        "0.54"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": ">=2500 g",
                        "unadjusted HR": "0.88",
                        "p-value": "0.92",
                        "adjusted HR": "0.93"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive replacement feeding"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": ">=2500 g",
                        "unadjusted HR": "0.88",
                        "p-value": "0.92",
                        "adjusted HR": "0.93"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Mixed feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.31 [0.04-2.42]",
                        "0.26"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": ">=2500 g",
                        "unadjusted HR": "0.88",
                        "p-value": "0.92",
                        "adjusted HR": "0.93"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Positive"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.31 [0.11-0.90]",
                        "0.032"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": ">=2500 g",
                        "unadjusted HR": "0.88",
                        "p-value": "0.92",
                        "adjusted HR": "0.93"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Negative"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": ">=2500 g",
                        "unadjusted HR": "0.88",
                        "p-value": "0.92",
                        "adjusted HR": "0.93"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "Birth weight": ">= 2500 g"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.70 [0.16-2.96]",
                        "0.63"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": ">=2500 g",
                        "unadjusted HR": "0.88",
                        "p-value": "0.92",
                        "adjusted HR": "0.93"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "Birth weight": ">= 2500 g"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.93 [0.21-4.12]",
                        "0.92"
                    ]
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": "<2500 g",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive breast feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "1.35 [0.52-3.49]",
                        "0.54"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": "<2500 g",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Exclusive replacement feeding"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": "<2500 g",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "mode of feeding": "Mixed feeding"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.31 [0.04-2.42]",
                        "0.26"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": "<2500 g",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Positive"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.31 [0.11-0.90]",
                        "0.032"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": "<2500 g",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "HIV Status": "Negative"
                    },
                    "measures": [
                        "Adjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": "<2500 g",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "Birth weight": ">= 2500 g"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "0.70 [0.16-2.96]",
                        "0.63"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Birth weight": "<2500 g",
                        "unadjusted HR": "Ref",
                        "p-value": "Ref",
                        "adjusted HR": "Ref"
                    },
                    "measures": "[Birth weight, HR]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "survival at 24 months",
                        "population": "HIV exposed infants",
                        "program": "Essos hospital center PMTCT program",
                        "Birth weight": "< 2500 g"
                    },
                    "measures": [
                        "Unadjusted Hazard Ratio",
                        "p-value"
                    ],
                    "outcomes": [
                        "Ref",
                        "Ref"
                    ]
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 8,
        "total_ground_truth_claims": 15,
        "number_of_matches": 7
    },
    "PMC5574138_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "meta regression",
                        "covariates": "length of follow-up, median CD4 cell counts, median age, year of publication, proportion of female"
                    },
                    "measures": "[study design, meta regression]",
                    "outcomes": "[outcome, parameter estimates of meta-regression]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Length of follow-up",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0138, 0.0666, (-0.1322\u20130.1046)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "meta regression",
                        "covariates": "length of follow-up, median CD4 cell counts, median age, year of publication, proportion of female"
                    },
                    "measures": "[study design, meta regression]",
                    "outcomes": "[outcome, parameter estimates of meta-regression]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median CD4 count",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0034, 0.0066, (-0.0150\u20130.0079)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "meta regression",
                        "covariates": "length of follow-up, median CD4 cell counts, median age, year of publication, proportion of female"
                    },
                    "measures": "[study design, meta regression]",
                    "outcomes": "[outcome, parameter estimates of meta-regression]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median age",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[0.0415, 0.0503, (-0.1013\u20130.0755)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "meta regression",
                        "covariates": "length of follow-up, median CD4 cell counts, median age, year of publication, proportion of female"
                    },
                    "measures": "[study design, meta regression]",
                    "outcomes": "[outcome, parameter estimates of meta-regression]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Year of publication",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[0.0637, 0.0815, (-0.1736\u20130.0980)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "meta regression",
                        "covariates": "length of follow-up, median CD4 cell counts, median age, year of publication, proportion of female"
                    },
                    "measures": "[study design, meta regression]",
                    "outcomes": "[outcome, parameter estimates of meta-regression]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Female proportion",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.5305, 1.4575, (-3.6792\u20132.6183)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "length of follow-up": "(-0.1322, -0.1046)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Length of follow-up",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0138, 0.0666, (-0.1322\u20130.1046)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "length of follow-up": "(-0.1322, -0.1046)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median CD4 count",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0034, 0.0066, (-0.0150\u20130.0079)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "length of follow-up": "(-0.1322, -0.1046)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median age",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[0.0415, 0.0503, (-0.1013\u20130.0755)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "length of follow-up": "(-0.1322, -0.1046)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Year of publication",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[0.0637, 0.0815, (-0.1736\u20130.0980)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "length of follow-up": "(-0.1322, -0.1046)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Female proportion",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.5305, 1.4575, (-3.6792\u20132.6183)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "median CD4 count": "(-0.0150, -0.0079)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Length of follow-up",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0138, 0.0666, (-0.1322\u20130.1046)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "median CD4 count": "(-0.0150, -0.0079)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median CD4 count",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0034, 0.0066, (-0.0150\u20130.0079)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "median CD4 count": "(-0.0150, -0.0079)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median age",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[0.0415, 0.0503, (-0.1013\u20130.0755)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "median CD4 count": "(-0.0150, -0.0079)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Year of publication",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[0.0637, 0.0815, (-0.1736\u20130.0980)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "median CD4 count": "(-0.0150, -0.0079)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Female proportion",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.5305, 1.4575, (-3.6792\u20132.6183)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "median age": "(-0.1013, -0.0755)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Length of follow-up",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0138, 0.0666, (-0.1322\u20130.1046)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "median age": "(-0.1013, -0.0755)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median CD4 count",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0034, 0.0066, (-0.0150\u20130.0079)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "median age": "(-0.1013, -0.0755)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median age",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[0.0415, 0.0503, (-0.1013\u20130.0755)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "median age": "(-0.1013, -0.0755)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Year of publication",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[0.0637, 0.0815, (-0.1736\u20130.0980)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "median age": "(-0.1013, -0.0755)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Female proportion",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.5305, 1.4575, (-3.6792\u20132.6183)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "year of publication": "(-0.1736, -0.0980)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Length of follow-up",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0138, 0.0666, (-0.1322\u20130.1046)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "year of publication": "(-0.1736, -0.0980)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median CD4 count",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0034, 0.0066, (-0.0150\u20130.0079)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "year of publication": "(-0.1736, -0.0980)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median age",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[0.0415, 0.0503, (-0.1013\u20130.0755)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "year of publication": "(-0.1736, -0.0980)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Year of publication",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[0.0637, 0.0815, (-0.1736\u20130.0980)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "female proportion": "(-3.6792, -2.6183)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Length of follow-up",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0138, 0.0666, (-0.1322\u20130.1046)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "female proportion": "(-3.6792, -2.6183)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median CD4 count",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.0034, 0.0066, (-0.0150\u20130.0079)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "female proportion": "(-3.6792, -2.6183)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Median age",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[0.0415, 0.0503, (-0.1013\u20130.0755)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "female proportion": "(-3.6792, -2.6183)"
                    },
                    "measures": "[metric, estimate]",
                    "outcomes": "[outcome, 95% CI]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Covariate": "Female proportion",
                        "Method": "Meta-regression"
                    },
                    "measures": "[Estimate, S.E, 95% CI]",
                    "outcomes": "[-0.5305, 1.4575, (-3.6792\u20132.6183)]"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 6,
        "total_ground_truth_claims": 5,
        "number_of_matches": 1
    },
    "PMC10294491_2": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "TDF/FTC",
                        "No. subjects": "2693",
                        "PYFU": "4386",
                        "Incident HIV infections": "11",
                        "Incidence rate (per 100 PYFU)": "0.251",
                        "Rate ratio (95% CI)": "REF"
                    },
                    "measures": "[Group, No. subjects, PYFU, Incident HIV infections, Incidence rate (per 100 PYFU), Rate ratio (95% CI)]",
                    "outcomes": "[TDF/FTC, 2693, 4386, 11, 0.251, REF]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Analysis": "Original analysis on rate ratio scale",
                        "Group": "TDF/FTC",
                        "No. subjects": "2693",
                        "PYFU": "4386",
                        "Incident HIV infections": "11",
                        "Method": "Rate ratio analysis"
                    },
                    "measures": "[Incidence rate (per 100 PYFU), Rate ratio (95% CI)]",
                    "outcomes": "[0.251, REF]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "TAF/FTC",
                        "No. subjects": "2694",
                        "PYFU": "4370",
                        "Incident HIV infections": "6",
                        "Incidence rate (per 100 PYFU)": "0.137",
                        "Rate ratio (95% CI)": "0.55 (0.20, 1.48)"
                    },
                    "measures": "[Group, No. subjects, PYFU, Incident HIV infections, Incidence rate (per 100 PYFU), Rate ratio (95% CI)]",
                    "outcomes": "[TAF/FTC, 2694, 4370, 6, 0.137, 0.55 (0.20, 1.48)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Analysis": "Original analysis on rate ratio scale",
                        "Group": "TAF/FTC",
                        "No. subjects": "2694",
                        "PYFU": "4370",
                        "Incident HIV infections": "6",
                        "Method": "Rate ratio analysis"
                    },
                    "measures": "[Incidence rate (per 100 PYFU), Rate ratio (95% CI)]",
                    "outcomes": "[0.137, 0.55 (0.20\u20131.48)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "TDF/FTC",
                        "PYFU": "4386",
                        "Observed infections": "11",
                        "Predicted infections": "90.4",
                        "Averted infections": "79.4",
                        "Averted infections ratio (95% CI)": "REF"
                    },
                    "measures": "[Group, PYFU, Observed infections, Predicted infections, Averted infections, Averted infections ratio (95% CI)]",
                    "outcomes": "[TDF/FTC, 4386, 11, 90.4, 79.4, REF]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Analysis": "Re-analysis using an averted infections framework",
                        "Group": "TDF/FTC",
                        "PYFU": "4386",
                        "Observed infections": "11",
                        "Predicted infections": "90.4",
                        "Method": "Averted infections framework (using counterfactual placebo incidence rate of 2.06 per 100 PYFU)"
                    },
                    "measures": "[Averted infections, Averted infections ratio (95% CI)]",
                    "outcomes": "[79.4, REF]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Group": "TAF/FTC",
                        "PYFU": "4370",
                        "Observed infections": "6",
                        "Predicted infections": "90.0",
                        "Averted infections": "84.0",
                        "Averted infections ratio (95% CI)": "1.06 (0.96\u20131.17)"
                    },
                    "measures": "[Group, PYFU, Observed infections, Predicted infections, Averted infections, Averted infections ratio (95% CI)]",
                    "outcomes": "[TAF/FTC, 4370, 6, 90.0, 84.0, 1.06 (0.96\u20131.17)]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Analysis": "Re-analysis using an averted infections framework",
                        "Group": "TAF/FTC",
                        "PYFU": "4370",
                        "Observed infections": "6",
                        "Predicted infections": "90.0",
                        "Method": "Averted infections framework (using counterfactual placebo incidence rate of 2.06 per 100 PYFU)"
                    },
                    "measures": "[Averted infections, Averted infections ratio (95% CI)]",
                    "outcomes": "[84.0, 1.06 (0.96-1.17)]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 7,
        "total_ground_truth_claims": 4,
        "number_of_matches": 4
    },
    "PMC6158807_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4/CD8 ratio": "< 0.3",
                        "No. of event": "21",
                        "Person-year of follow-up": "184",
                        "Rate per 100 person-year": "95% CI, 11.42 (7.45\u201317.52)"
                    },
                    "measures": "[Citation, The incidence rates of non-AIDS composite events were significantly different between the cutoffs for CD4/CD8 ratio, with 11.42 per 100 PYS (95% CI 7.45\u201317.52) for current CD4/CD8 ratio < 0.3 and 2.23 per 100 PYS (1.77\u20132.81) for ratio > 0.45]",
                    "outcomes": "[p-value, < 0.001]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "Composite endpoint (all participants)",
                        "Sample size": "692",
                        "No. of events": "123",
                        "Person-years of follow-up": "4071",
                        "Method": "Event rate across total follow-up"
                    },
                    "measures": "[Rate per 100 person-years (95% CI)]",
                    "outcomes": "[3.02 (2.53\u20133.61)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4/CD8 ratio": "< 0.3",
                        "No. of event": "21",
                        "Person-year of follow-up": "184",
                        "Rate per 100 person-year": "95% CI, 11.42 (7.45\u201317.52)"
                    },
                    "measures": "[Citation, The incidence rates of non-AIDS composite events were significantly different between the cutoffs for CD4/CD8 ratio, with 11.42 per 100 PYS (95% CI 7.45\u201317.52) for current CD4/CD8 ratio < 0.3 and 2.23 per 100 PYS (1.77\u20132.81) for ratio > 0.45]",
                    "outcomes": "[p-value, < 0.001]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "Current CD4/CD8 ratio < 0.3",
                        "No. of events": "21",
                        "Person-years of follow-up": "184",
                        "Method": "Rate stratified by CD4/CD8 ratio group"
                    },
                    "measures": "[Rate per 100 person-years (95% CI)]",
                    "outcomes": "[11.42 (7.45\u201317.52)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4/CD8 ratio": "0.30\u20130.45",
                        "No. of event": "28",
                        "Person-year of follow-up": "496",
                        "Rate per 100 person-year": "95% CI, 5.64 (3.90\u20138.17)"
                    },
                    "measures": "[Citation, The incidence rates of non-AIDS composite events were significantly different between the cutoffs for CD4/CD8 ratio, with 11.42 per 100 PYS (95% CI 7.45\u201317.52) for current CD4/CD8 ratio < 0.3 and 2.23 per 100 PYS (1.77\u20132.81) for ratio > 0.45]",
                    "outcomes": "[]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "Composite endpoint (all participants)",
                        "Sample size": "692",
                        "No. of events": "123",
                        "Person-years of follow-up": "4071",
                        "Method": "Event rate across total follow-up"
                    },
                    "measures": "[Rate per 100 person-years (95% CI)]",
                    "outcomes": "[3.02 (2.53\u20133.61)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4/CD8 ratio": "0.30\u20130.45",
                        "No. of event": "28",
                        "Person-year of follow-up": "496",
                        "Rate per 100 person-year": "95% CI, 5.64 (3.90\u20138.17)"
                    },
                    "measures": "[Citation, The incidence rates of non-AIDS composite events were significantly different between the cutoffs for CD4/CD8 ratio, with 11.42 per 100 PYS (95% CI 7.45\u201317.52) for current CD4/CD8 ratio < 0.3 and 2.23 per 100 PYS (1.77\u20132.81) for ratio > 0.45]",
                    "outcomes": "[]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "Current CD4/CD8 ratio 0.30\u20130.45",
                        "No. of events": "28",
                        "Person-years of follow-up": "496",
                        "Method": "Rate stratified by CD4/CD8 ratio group"
                    },
                    "measures": "[Rate per 100 person-years (95% CI)]",
                    "outcomes": "[5.64 (3.90\u20138.17)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4/CD8 ratio": "> 0.45",
                        "No. of event": "72",
                        "Person-year of follow-up": "3227",
                        "Rate per 100 person-year": "95% CI, 2.23 (1.77\u20132.81)"
                    },
                    "measures": "[Citation, The incidence rates of non-AIDS composite events were significantly different between the cutoffs for CD4/CD8 ratio, with 11.42 per 100 PYS (95% CI 7.45\u201317.52) for current CD4/CD8 ratio < 0.3 and 2.23 per 100 PYS (1.77\u20132.81) for ratio > 0.45]",
                    "outcomes": "[p-value, < 0.001]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "Composite endpoint (all participants)",
                        "Sample size": "692",
                        "No. of events": "123",
                        "Person-years of follow-up": "4071",
                        "Method": "Event rate across total follow-up"
                    },
                    "measures": "[Rate per 100 person-years (95% CI)]",
                    "outcomes": "[3.02 (2.53\u20133.61)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4/CD8 ratio": "> 0.45",
                        "No. of event": "72",
                        "Person-year of follow-up": "3227",
                        "Rate per 100 person-year": "95% CI, 2.23 (1.77\u20132.81)"
                    },
                    "measures": "[Citation, The incidence rates of non-AIDS composite events were significantly different between the cutoffs for CD4/CD8 ratio, with 11.42 per 100 PYS (95% CI 7.45\u201317.52) for current CD4/CD8 ratio < 0.3 and 2.23 per 100 PYS (1.77\u20132.81) for ratio > 0.45]",
                    "outcomes": "[p-value, < 0.001]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "Current CD4/CD8 ratio > 0.45",
                        "No. of events": "72",
                        "Person-years of follow-up": "3227",
                        "Method": "Rate stratified by CD4/CD8 ratio group"
                    },
                    "measures": "[Rate per 100 person-years (95% CI)]",
                    "outcomes": "[2.23 (1.77\u20132.81)]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 3,
        "total_ground_truth_claims": 4,
        "number_of_matches": 3
    },
    "PMC7522205_2": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "Patients": "1687 (59.3)",
                        "CD4+ median (IQR)": "111 (31\u2013279)",
                        "Coefficient": "0",
                        "95% CI": "",
                        "P": "0"
                    },
                    "measures": "[HIV-1 Genotype, CRF01_AE, Patients, 1687, CD4+ median (IQR), 111, Coefficient, 0, 95% CI, P]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "Patients": "1687 (59.3%)",
                        "CD4+ median (IQR)": "111 (31\u2013279)",
                        "Reference group": "Yes"
                    },
                    "measures": "[Unadjusted Coefficient, 95% CI, P]",
                    "outcomes": "[0, \u2013, \u2013]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "CD4+ median (IQR)": "111 (31\u2013279)"
                    },
                    "measures": "[HIV-1 Genotype, CRF01_AE, CD4+ median (IQR), 111]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "Patients": "1687 (59.3%)",
                        "CD4+ median (IQR)": "111 (31\u2013279)",
                        "Reference group": "Yes"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[0, \u2013, \u2013]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "CD4+ median (IQR)": "111 (31\u2013279)"
                    },
                    "measures": "[HIV-1 Genotype, CRF01_AE, CD4+ median (IQR), 111]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "Patients": "254 (8.9%)",
                        "CD4+ median (IQR)": "250 (156\u2013377)"
                    },
                    "measures": "[Unadjusted Coefficient, 95% CI, P]",
                    "outcomes": "[139, 117\u2013161, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "CD4+ median (IQR)": "111 (31\u2013279)"
                    },
                    "measures": "[HIV-1 Genotype, CRF01_AE, CD4+ median (IQR), 111]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "Patients": "254 (8.9%)",
                        "CD4+ median (IQR)": "250 (156\u2013377)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[113, 86\u2013140, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "CD4+ median (IQR)": "111 (31\u2013279)"
                    },
                    "measures": "[HIV-1 Genotype, CRF01_AE, CD4+ median (IQR), 111]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "Patients": "728 (25.6%)",
                        "CD4+ median (IQR)": "205 (108\u2013327)"
                    },
                    "measures": "[Unadjusted Coefficient, 95% CI, P]",
                    "outcomes": "[94, 73\u2013115, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "CD4+ median (IQR)": "111 (31\u2013279)"
                    },
                    "measures": "[HIV-1 Genotype, CRF01_AE, CD4+ median (IQR), 111]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "Patients": "728 (25.6%)",
                        "CD4+ median (IQR)": "205 (108\u2013327)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[80, 65\u201395, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "CD4+ median (IQR)": "111 (31\u2013279)"
                    },
                    "measures": "[HIV-1 Genotype, CRF01_AE, CD4+ median (IQR), 111]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2%)",
                        "CD4+ median (IQR)": "198 (89\u2013355)"
                    },
                    "measures": "[Unadjusted Coefficient, 95% CI, P]",
                    "outcomes": "[87, 46\u2013128, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "CD4+ median (IQR)": "111 (31\u2013279)"
                    },
                    "measures": "[HIV-1 Genotype, CRF01_AE, CD4+ median (IQR), 111]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2%)",
                        "CD4+ median (IQR)": "198 (89\u2013355)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[72, 37\u2013107, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "Patients": "254 (8.9)",
                        "CD4+ median (IQR)": "250 (156\u2013377)",
                        "Coefficient": "139",
                        "95% CI": "(117\u2013161)",
                        "P": "<0.001"
                    },
                    "measures": "[HIV-1 Genotype, CRF07_BC, Patients, 254, CD4+ median (IQR), 250, Coefficient, 139, 95% CI, P]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "Patients": "1687 (59.3%)",
                        "CD4+ median (IQR)": "111 (31\u2013279)",
                        "Reference group": "Yes"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[0, \u2013, \u2013]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "Patients": "254 (8.9)",
                        "CD4+ median (IQR)": "250 (156\u2013377)",
                        "Coefficient": "139",
                        "95% CI": "(117\u2013161)",
                        "P": "<0.001"
                    },
                    "measures": "[HIV-1 Genotype, CRF07_BC, Patients, 254, CD4+ median (IQR), 250, Coefficient, 139, 95% CI, P]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "Patients": "254 (8.9%)",
                        "CD4+ median (IQR)": "250 (156\u2013377)"
                    },
                    "measures": "[Unadjusted Coefficient, 95% CI, P]",
                    "outcomes": "[139, 117\u2013161, <0.001]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "CD4+ median (IQR)": "250 (156\u2013377)"
                    },
                    "measures": "[HIV-1 Genotype, CRF07_BC, CD4+ median (IQR), 250]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "Patients": "1687 (59.3%)",
                        "CD4+ median (IQR)": "111 (31\u2013279)",
                        "Reference group": "Yes"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[0, \u2013, \u2013]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "CD4+ median (IQR)": "250 (156\u2013377)"
                    },
                    "measures": "[HIV-1 Genotype, CRF07_BC, CD4+ median (IQR), 250]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "Patients": "254 (8.9%)",
                        "CD4+ median (IQR)": "250 (156\u2013377)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[113, 86\u2013140, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "CD4+ median (IQR)": "250 (156\u2013377)"
                    },
                    "measures": "[HIV-1 Genotype, CRF07_BC, CD4+ median (IQR), 250]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "Patients": "728 (25.6%)",
                        "CD4+ median (IQR)": "205 (108\u2013327)"
                    },
                    "measures": "[Unadjusted Coefficient, 95% CI, P]",
                    "outcomes": "[94, 73\u2013115, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "CD4+ median (IQR)": "250 (156\u2013377)"
                    },
                    "measures": "[HIV-1 Genotype, CRF07_BC, CD4+ median (IQR), 250]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "Patients": "728 (25.6%)",
                        "CD4+ median (IQR)": "205 (108\u2013327)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[80, 65\u201395, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "CD4+ median (IQR)": "250 (156\u2013377)"
                    },
                    "measures": "[HIV-1 Genotype, CRF07_BC, CD4+ median (IQR), 250]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2%)",
                        "CD4+ median (IQR)": "198 (89\u2013355)"
                    },
                    "measures": "[Unadjusted Coefficient, 95% CI, P]",
                    "outcomes": "[87, 46\u2013128, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "CD4+ median (IQR)": "250 (156\u2013377)"
                    },
                    "measures": "[HIV-1 Genotype, CRF07_BC, CD4+ median (IQR), 250]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2%)",
                        "CD4+ median (IQR)": "198 (89\u2013355)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[72, 37\u2013107, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "Patients": "728 (25.6)",
                        "CD4+ median (IQR)": "205 (108\u2013327)",
                        "Coefficient": "94",
                        "95% CI": "(73\u2013115)",
                        "P": "<0.001"
                    },
                    "measures": "[HIV-1 Genotype, CRF08_BC, Patients, 728, CD4+ median (IQR), 205, Coefficient, 94, 95% CI, P]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "Patients": "1687 (59.3%)",
                        "CD4+ median (IQR)": "111 (31\u2013279)",
                        "Reference group": "Yes"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[0, \u2013, \u2013]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "Patients": "728 (25.6)",
                        "CD4+ median (IQR)": "205 (108\u2013327)",
                        "Coefficient": "94",
                        "95% CI": "(73\u2013115)",
                        "P": "<0.001"
                    },
                    "measures": "[HIV-1 Genotype, CRF08_BC, Patients, 728, CD4+ median (IQR), 205, Coefficient, 94, 95% CI, P]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "Patients": "254 (8.9%)",
                        "CD4+ median (IQR)": "250 (156\u2013377)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[113, 86\u2013140, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "Patients": "728 (25.6)",
                        "CD4+ median (IQR)": "205 (108\u2013327)",
                        "Coefficient": "94",
                        "95% CI": "(73\u2013115)",
                        "P": "<0.001"
                    },
                    "measures": "[HIV-1 Genotype, CRF08_BC, Patients, 728, CD4+ median (IQR), 205, Coefficient, 94, 95% CI, P]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "Patients": "728 (25.6%)",
                        "CD4+ median (IQR)": "205 (108\u2013327)"
                    },
                    "measures": "[Unadjusted Coefficient, 95% CI, P]",
                    "outcomes": "[94, 73\u2013115, <0.001]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "CD4+ median (IQR)": "205 (108\u2013327)"
                    },
                    "measures": "[HIV-1 Genotype, CRF08_BC, CD4+ median (IQR), 205]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "Patients": "1687 (59.3%)",
                        "CD4+ median (IQR)": "111 (31\u2013279)",
                        "Reference group": "Yes"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[0, \u2013, \u2013]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "CD4+ median (IQR)": "205 (108\u2013327)"
                    },
                    "measures": "[HIV-1 Genotype, CRF08_BC, CD4+ median (IQR), 205]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "Patients": "254 (8.9%)",
                        "CD4+ median (IQR)": "250 (156\u2013377)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[113, 86\u2013140, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "CD4+ median (IQR)": "205 (108\u2013327)"
                    },
                    "measures": "[HIV-1 Genotype, CRF08_BC, CD4+ median (IQR), 205]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "Patients": "728 (25.6%)",
                        "CD4+ median (IQR)": "205 (108\u2013327)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[80, 65\u201395, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "CD4+ median (IQR)": "205 (108\u2013327)"
                    },
                    "measures": "[HIV-1 Genotype, CRF08_BC, CD4+ median (IQR), 205]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2%)",
                        "CD4+ median (IQR)": "198 (89\u2013355)"
                    },
                    "measures": "[Unadjusted Coefficient, 95% CI, P]",
                    "outcomes": "[87, 46\u2013128, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "CD4+ median (IQR)": "205 (108\u2013327)"
                    },
                    "measures": "[HIV-1 Genotype, CRF08_BC, CD4+ median (IQR), 205]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2%)",
                        "CD4+ median (IQR)": "198 (89\u2013355)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[72, 37\u2013107, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2)",
                        "CD4+ median (IQR)": "198 (89\u2013355)",
                        "Coefficient": "87",
                        "95% CI": "(46\u2013128)",
                        "P": "<0.001"
                    },
                    "measures": "[HIV-1 Genotype, Others, Patients, 176, CD4+ median (IQR), 198, Coefficient, 87, 95% CI, P]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "Patients": "1687 (59.3%)",
                        "CD4+ median (IQR)": "111 (31\u2013279)",
                        "Reference group": "Yes"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[0, \u2013, \u2013]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2)",
                        "CD4+ median (IQR)": "198 (89\u2013355)",
                        "Coefficient": "87",
                        "95% CI": "(46\u2013128)",
                        "P": "<0.001"
                    },
                    "measures": "[HIV-1 Genotype, Others, Patients, 176, CD4+ median (IQR), 198, Coefficient, 87, 95% CI, P]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "Patients": "254 (8.9%)",
                        "CD4+ median (IQR)": "250 (156\u2013377)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[113, 86\u2013140, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2)",
                        "CD4+ median (IQR)": "198 (89\u2013355)",
                        "Coefficient": "87",
                        "95% CI": "(46\u2013128)",
                        "P": "<0.001"
                    },
                    "measures": "[HIV-1 Genotype, Others, Patients, 176, CD4+ median (IQR), 198, Coefficient, 87, 95% CI, P]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "Patients": "728 (25.6%)",
                        "CD4+ median (IQR)": "205 (108\u2013327)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[80, 65\u201395, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2)",
                        "CD4+ median (IQR)": "198 (89\u2013355)",
                        "Coefficient": "87",
                        "95% CI": "(46\u2013128)",
                        "P": "<0.001"
                    },
                    "measures": "[HIV-1 Genotype, Others, Patients, 176, CD4+ median (IQR), 198, Coefficient, 87, 95% CI, P]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2%)",
                        "CD4+ median (IQR)": "198 (89\u2013355)"
                    },
                    "measures": "[Unadjusted Coefficient, 95% CI, P]",
                    "outcomes": "[87, 46\u2013128, <0.001]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "CD4+ median (IQR)": "198 (89\u2013355)"
                    },
                    "measures": "[HIV-1 Genotype, Others, CD4+ median (IQR), 198]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF01_AE",
                        "Patients": "1687 (59.3%)",
                        "CD4+ median (IQR)": "111 (31\u2013279)",
                        "Reference group": "Yes"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[0, \u2013, \u2013]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "CD4+ median (IQR)": "198 (89\u2013355)"
                    },
                    "measures": "[HIV-1 Genotype, Others, CD4+ median (IQR), 198]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF07_BC",
                        "Patients": "254 (8.9%)",
                        "CD4+ median (IQR)": "250 (156\u2013377)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[113, 86\u2013140, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "CD4+ median (IQR)": "198 (89\u2013355)"
                    },
                    "measures": "[HIV-1 Genotype, Others, CD4+ median (IQR), 198]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "CRF08_BC",
                        "Patients": "728 (25.6%)",
                        "CD4+ median (IQR)": "205 (108\u2013327)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[80, 65\u201395, <0.001]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "CD4+ median (IQR)": "198 (89\u2013355)"
                    },
                    "measures": "[HIV-1 Genotype, Others, CD4+ median (IQR), 198]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV-1 Genotype": "Others",
                        "Patients": "176 (6.2%)",
                        "CD4+ median (IQR)": "198 (89\u2013355)",
                        "Vairables adjusted for": "age at diagnosis, sex, marital status, ethnicity, education level, occupation, transmission route, and year of HIV infection diagnosis"
                    },
                    "measures": "[Adjusted Coefficient, 95% CI, P]",
                    "outcomes": "[72, 37\u2013107, <0.001]"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 8,
        "total_ground_truth_claims": 8,
        "number_of_matches": 4
    },
    "PMC7414801_2": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "133",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "135",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[36.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "114",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[39.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[19.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[17.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.2]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[13.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "106",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[23.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "118",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "107",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[41.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[11.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[2.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[7.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV Seroconverter Data Available by Months Since HIV Detection Visit",
                        "participants": "382",
                        "analysis": "as-randomized",
                        "continuous use": "331",
                        "DMPA-IM": "80%",
                        "copper IUD": "87%",
                        "LNG implant": "94%"
                    },
                    "measures": "[study, HIV Seroconverter Data Available by Months Since HIV Detection Visit]",
                    "outcomes": [
                        "[participants, 382]",
                        "[analysis, as-randomized]",
                        "[continuous use, 331]",
                        "[DMPA-IM, 80%]",
                        "[copper IUD, 87%]",
                        "[LNG implant, 94%]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "133",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "135",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[36.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "114",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[39.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[19.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[17.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.2]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[13.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "106",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[23.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "118",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "107",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[41.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[11.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[2.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[7.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV detection visit": "HIV detection visit",
                        "M3": "30",
                        "M6": "19",
                        "M9": "11",
                        "M12": "7",
                        "M15": "4"
                    },
                    "measures": "[HIV detection visit, HIV detection visit]",
                    "outcomes": [
                        "[M3, 30]",
                        "[M6, 19]",
                        "[M9, 11]",
                        "[M12, 7]",
                        "[M15, 4]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "133",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "135",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[36.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "114",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[39.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[19.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[17.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.2]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[13.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "106",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[23.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "118",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "107",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[41.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[11.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[2.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[7.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "n": "330"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[n, 381]",
                        "[n, 330]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "133",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "135",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[36.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "114",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[39.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[19.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[17.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.2]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[13.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "106",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[23.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "118",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "107",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[41.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[11.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[2.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[7.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "n": "331"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[n, 382]",
                        "[n, 331]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "133",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "135",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[36.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "114",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[39.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[19.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[17.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.2]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[13.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "106",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[23.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "118",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "107",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[41.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[11.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[2.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[7.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "114",
                        "M6": "73",
                        "M9": "43",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 114]",
                        "[M6, 73]",
                        "[M9, 43]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "133",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "135",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[36.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "114",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[39.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[19.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[17.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.2]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[13.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "106",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[23.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "118",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "107",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[41.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[11.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[2.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[7.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "115",
                        "M6": "73",
                        "M9": "44",
                        "M12": "26",
                        "M15": "17"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 115]",
                        "[M6, 73]",
                        "[M9, 44]",
                        "[M12, 26]",
                        "[M15, 17]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "133",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "135",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[36.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "114",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[39.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[19.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[17.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.2]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[13.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "106",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[23.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "118",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "107",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[41.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[11.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[2.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[7.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV VL": "HIV VL",
                        "M3": "99",
                        "M6": "65",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[HIV VL, HIV VL]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 65]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "133",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "135",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[36.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "HIV detection visit": "114",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[39.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[19.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[17.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.2]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "As-randomized",
                        "sample size": 382,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[13.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "106",
                        "method": "DMPA-IM",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[23.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "118",
                        "method": "Copper IUD",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[34.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "HIV detection visit": "107",
                        "method": "LNG implant",
                        "month": "M3"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[41.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[9.3]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M6"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[18.1]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[11.8]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M9"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[2.4]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[6.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M12"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[15.6]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "DMPA-IM",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[7.7]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "Copper IUD",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[10.0]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "CD4": "CD4",
                        "M3": "99",
                        "M6": "64",
                        "M9": "40",
                        "M12": "25",
                        "M15": "14"
                    },
                    "measures": "[CD4, CD4]",
                    "outcomes": [
                        "[M3, 99]",
                        "[M6, 64]",
                        "[M9, 40]",
                        "[M12, 25]",
                        "[M15, 14]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "summary": "HIV Seroconverter Data",
                        "timepoint": "HIV detection visit",
                        "group": "Consistent-use",
                        "sample size": 331,
                        "method": "LNG implant",
                        "month": "M15"
                    },
                    "measures": "[Attended visit %]",
                    "outcomes": "[14.3]"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 8,
        "total_ground_truth_claims": 30,
        "number_of_matches": 0
    },
    "PMC9624454_2": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[30.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.8%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[29.0%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.2%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[38.1%, 0.061]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[8.5%, 0.18]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[2.4 (2.0\u20132.9), 0.24]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[37.1%, 0.088]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[6.2%, 0.56]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[40.0%, 0.39]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[20.0%, 0.015]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "All children",
                        "No.": "1024",
                        "CMV Viremia": "No. (%), 314 (30.7)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 59 (5.8)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[30.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.8%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[29.0%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.2%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[38.1%, 0.061]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[8.5%, 0.18]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[2.4 (2.0\u20132.9), 0.24]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[37.1%, 0.088]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[6.2%, 0.56]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[40.0%, 0.39]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[20.0%, 0.015]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV unexposed",
                        "No.": "872",
                        "CMV Viremia": "No. (%), 253 (29.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 45 (5.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.3 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed",
                        "No.": "118",
                        "CMV Viremia": "No. (%), 45 (38.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 10 (8.5)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (2.0\u20132.9)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[30.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed",
                        "No.": "118",
                        "CMV Viremia": "No. (%), 45 (38.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 10 (8.5)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (2.0\u20132.9)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.8%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed",
                        "No.": "118",
                        "CMV Viremia": "No. (%), 45 (38.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 10 (8.5)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (2.0\u20132.9)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed",
                        "No.": "118",
                        "CMV Viremia": "No. (%), 45 (38.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 10 (8.5)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (2.0\u20132.9)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[29.0%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed",
                        "No.": "118",
                        "CMV Viremia": "No. (%), 45 (38.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 10 (8.5)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (2.0\u20132.9)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.2%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed",
                        "No.": "118",
                        "CMV Viremia": "No. (%), 45 (38.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 10 (8.5)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (2.0\u20132.9)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed",
                        "No.": "118",
                        "CMV Viremia": "No. (%), 45 (38.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 10 (8.5)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (2.0\u20132.9)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[38.1%, 0.061]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed",
                        "No.": "118",
                        "CMV Viremia": "No. (%), 45 (38.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 10 (8.5)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (2.0\u20132.9)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[8.5%, 0.18]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed",
                        "No.": "118",
                        "CMV Viremia": "No. (%), 45 (38.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 10 (8.5)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (2.0\u20132.9)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[2.4 (2.0\u20132.9), 0.24]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[30.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.8%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[29.0%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.2%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[38.1%, 0.061]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[8.5%, 0.18]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[37.1%, 0.088]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[6.2%, 0.56]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[40.0%, 0.39]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[20.0%, 0.015]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV exposed uninfected",
                        "No.": "97",
                        "CMV Viremia": "No. (%), 36 (37.1)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 6 (6.2)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 2.4 (1.9\u20132.7)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[30.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.8%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[29.0%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.2%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[38.1%, 0.061]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[8.5%, 0.18]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[37.1%, 0.088]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[6.2%, 0.56]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[40.0%, 0.39]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[20.0%, 0.015]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV Exposure": "HIV infected",
                        "No.": "15",
                        "CMV Viremia": "No. (%), 6 (40.0)",
                        "CMV Viremia \u2264 1000 IU/mL": "No. (%), 3 (20.0)",
                        "log10 CMV IU/mL in Viremics": "Median (IQR), 3.2 (2.6\u20135.3)"
                    },
                    "measures": "[HIV Exposure, HIV, metric]",
                    "outcomes": "[HIV Exposure, HIV, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[30.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.8%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[29.0%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.2%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[38.1%, 0.061]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[8.5%, 0.18]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[37.1%, 0.088]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[6.2%, 0.56]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[40.0%, 0.39]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[20.0%, 0.015]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[30.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.8%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[29.0%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.2%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[38.1%, 0.061]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[8.5%, 0.18]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[37.1%, 0.088]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[6.2%, 0.56]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[40.0%, 0.39]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[20.0%, 0.015]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison to CMV detection \u2264 1000 IU/mL",
                        "in HIV-unexposed children": "\u03c7\u00b2 test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[30.7%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.8%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "All children",
                        "Total No.": "1024",
                        "Method": "Overall CMV viremia analysis across all groups"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia (%)]",
                    "outcomes": "[29.0%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%)]",
                    "outcomes": "[5.2%]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV unexposed",
                        "Total No.": "872",
                        "Method": "Reference group for all comparisons"
                    },
                    "measures": "[log10 CMV IU/mL in Viremics (Median, IQR)]",
                    "outcomes": "[2.3 (1.9\u20132.7)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[38.1%, 0.061]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed",
                        "Total No.": "118",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[8.5%, 0.18]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[37.1%, 0.088]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[6.2%, 0.56]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV exposed uninfected",
                        "Total No.": "97",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[2.4 (1.9\u20132.7), 0.74]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia (%), P Value]",
                    "outcomes": "[40.0%, 0.39]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[CMV Viremia \u2265 1000 IU/mL (%), P Value]",
                    "outcomes": "[20.0%, 0.015]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Comparison of CMV viral load distribution",
                        "to HIV-unexposed children": "Wilcoxon rank-sum test"
                    },
                    "measures": "[Footnote, metric]",
                    "outcomes": "[Footnote, outcome]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "HIV Status": "HIV infected",
                        "Total No.": "15",
                        "Method": "Comparison to HIV unexposed group"
                    },
                    "measures": "[log10 CMV IU/mL (Median, IQR), P Value]",
                    "outcomes": "[3.2 (2.6\u20135.3), 0.012]"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 8,
        "total_ground_truth_claims": 15,
        "number_of_matches": 1
    },
    "PMC4549947_4": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "ORs and 95% CIs",
                        "outcome": "1.3",
                        "gender": "Females",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, ORs and 95% CIs]",
                        "[outcome, 1.3]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "executive function",
                        "gender": "females",
                        "p-interaction": "0.35"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.3]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "ORs and 95% CIs",
                        "outcome": "3.5",
                        "gender": "Males",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, ORs and 95% CIs]",
                        "[outcome, 3.5]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "executive function",
                        "gender": "males",
                        "p-interaction": "0.35"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[3.5, 1.5\u20135.5, 0.008]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "ORs and 95% CIs",
                        "outcome": "2.6",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, ORs and 95% CIs]",
                        "[outcome, 2.6]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "executive function",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.05"
                    },
                    "measures": "[OR]",
                    "outcomes": "[2.6]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "ORs and 95% CIs",
                        "outcome": "3.1",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, ORs and 95% CIs]",
                        "[outcome, 3.1]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "executive function",
                        "race/ethnicity": "African American",
                        "p-interaction": "0.05"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[3.1, 2.3\u20133.5, 0.01]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "ORs and 95% CIs",
                        "outcome": "2.6",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, ORs and 95% CIs]",
                        "[outcome, 2.6]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "executive function",
                        "context": "alcohol use"
                    },
                    "measures": "[OR]",
                    "outcomes": "[2.6]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.008",
                        "gender": "Males",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.008]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.008",
                        "gender": "Males",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.008]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.008",
                        "gender": "Males",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.008]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.008",
                        "gender": "Males",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.008]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "African American",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.008",
                        "gender": "Males",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.008]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "context": "alcohol use",
                        "p-interaction": "0.32"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.6, 1.4\u20132.4, 0.03]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "African American",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "context": "alcohol use",
                        "p-interaction": "0.32"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.6, 1.4\u20132.4, 0.03]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "African American",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "context": "alcohol use",
                        "p-interaction": "0.32"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.6, 1.4\u20132.4, 0.03]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "African American",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "context": "alcohol use",
                        "p-interaction": "0.32"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.6, 1.4\u20132.4, 0.03]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.35",
                        "gender": "Males",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.35]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.35",
                        "gender": "Males",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.35]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.35",
                        "gender": "Males",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.35]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.35",
                        "gender": "Males",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.35]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "African American",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.35",
                        "gender": "Males",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.35]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "context": "alcohol use",
                        "p-interaction": "0.32"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.6, 1.4\u20132.4, 0.03]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "African American",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "context": "alcohol use",
                        "p-interaction": "0.32"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.6, 1.4\u20132.4, 0.03]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.013",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.013]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.013",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.013]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.013",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.013]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.013",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.013]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "African American",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.5]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.013",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.013]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "context": "alcohol use",
                        "p-interaction": "0.32"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.6, 1.4\u20132.4, 0.03]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "African American",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "African American",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.5]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "context": "alcohol use",
                        "p-interaction": "0.32"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.6, 1.4\u20132.4, 0.03]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "context": "alcohol use",
                        "p-interaction": "0.32"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.6, 1.4\u20132.4, 0.03]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.03",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.03]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.03",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.03]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.03",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.03]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.03",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.03]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "context": "alcohol use",
                        "p-interaction": "0.32"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.6, 1.4\u20132.4, 0.03]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "Hispanics",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.013",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.013]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.013",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.013]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.013",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.013]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.35",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.35]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.35",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.35]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.35",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.35]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.013",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.013]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.013",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.013]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.013",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.013]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.32",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.32]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.01",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.01]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.72",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.72]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "females",
                        "p-intraction": "0.013"
                    },
                    "measures": "[OR]",
                    "outcomes": "[0.9]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "gender": "males",
                        "p-interaction": "0.013"
                    },
                    "measures": "[OR, 95% CI, p-value]",
                    "outcomes": "[1.8, 1.2\u20132.9, 0.01]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use",
                        "metric": "p-value",
                        "outcome": "0.05",
                        "gender": "-",
                        "race/ethnicity": "-",
                        "alcohol use": "-"
                    },
                    "measures": "[study, DRD2 associations with cognitive flexibility and executive function in gender, race/ethnicity groups and alcohol use]",
                    "outcomes": [
                        "[metric, p-value]",
                        "[outcome, 0.05]"
                    ]
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "DRD2 associations with cognitive flexibility and executive function",
                        "variant": "DRD2 rs6277",
                        "trait": "cognitive flexibility",
                        "race/ethnicity": "Hispanics",
                        "p-interaction": "0.72"
                    },
                    "measures": "[OR]",
                    "outcomes": "[1.9]"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 28,
        "total_ground_truth_claims": 10,
        "number_of_matches": 7
    },
    "PMC6694514_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "20",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "12",
                        "30.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "20",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "15",
                        "25.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "20",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "20",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "20",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "20",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "20",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "20",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "20",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "20",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "42",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "12",
                        "30.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "42",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "15",
                        "25.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "42",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "42",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "42",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "42",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "42",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "42",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "42",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "42",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "34",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "12",
                        "30.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "34",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "15",
                        "25.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "34",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "34",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "34",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "34",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "34",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "34",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "34",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "34",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "220",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "12",
                        "30.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "220",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "15",
                        "25.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "220",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "220",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "220",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "220",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "220",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "220",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "220",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "220",
                        "AE_type": "\u22651 grade 3 or 4 AE"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "11",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "12",
                        "30.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "11",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "15",
                        "25.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "11",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "11",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "11",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "11",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "11",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "11",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "11",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "11",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "14",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "12",
                        "30.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "14",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "15",
                        "25.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "14",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "14",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "14",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "14",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "14",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "14",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "14",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "14",
                        "AE_type": "at least possibly related to treatment"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-positive",
                        "Patient_group": "6",
                        "AE_type": "hepatobiliary disorders"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "12",
                        "30.0%"
                    ]
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "HIV_status": "HIV-negative",
                        "Patient_group": "9",
                        "AE_type": "hepatobiliary disorders"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Hepatobiliary disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "15",
                        "25.0%"
                    ]
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Hepatobiliary disorders",
                        "HIV_positive_Patients": "12",
                        "HIV_negative_Patients": "15"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Hepatobiliary disorders",
                        "HIV_positive_Patients": "12",
                        "HIV_negative_Patients": "15"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Hepatobiliary disorders",
                        "HIV_positive_Patients": "12",
                        "HIV_negative_Patients": "15"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Hepatobiliary disorders",
                        "HIV_positive_Patients": "12",
                        "HIV_negative_Patients": "15"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Hepatobiliary disorders",
                        "HIV_positive_Patients": "12",
                        "HIV_negative_Patients": "15"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Hepatobiliary disorders",
                        "HIV_positive_Patients": "12",
                        "HIV_negative_Patients": "15"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Hepatobiliary disorders",
                        "HIV_positive_Patients": "12",
                        "HIV_negative_Patients": "15"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Hepatobiliary disorders",
                        "HIV_positive_Patients": "12",
                        "HIV_negative_Patients": "15"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Respiratory and thoracic disorders",
                        "HIV_positive_Patients": "7",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Respiratory and thoracic disorders",
                        "HIV_positive_Patients": "7",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Respiratory and thoracic disorders",
                        "HIV_positive_Patients": "7",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Respiratory and thoracic disorders",
                        "HIV_positive_Patients": "7",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Respiratory and thoracic disorders",
                        "HIV_positive_Patients": "7",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Respiratory and thoracic disorders",
                        "HIV_positive_Patients": "7",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Respiratory and thoracic disorders",
                        "HIV_positive_Patients": "7",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Respiratory and thoracic disorders",
                        "HIV_positive_Patients": "7",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Blood and lymphatic disorders",
                        "HIV_positive_Patients": "6",
                        "HIV_negative_Patients": "10"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Blood and lymphatic disorders",
                        "HIV_positive_Patients": "6",
                        "HIV_negative_Patients": "10"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Blood and lymphatic disorders",
                        "HIV_positive_Patients": "6",
                        "HIV_negative_Patients": "10"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Blood and lymphatic disorders",
                        "HIV_positive_Patients": "6",
                        "HIV_negative_Patients": "10"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Blood and lymphatic disorders",
                        "HIV_positive_Patients": "6",
                        "HIV_negative_Patients": "10"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Blood and lymphatic disorders",
                        "HIV_positive_Patients": "6",
                        "HIV_negative_Patients": "10"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Blood and lymphatic disorders",
                        "HIV_positive_Patients": "6",
                        "HIV_negative_Patients": "10"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Blood and lymphatic disorders",
                        "HIV_positive_Patients": "6",
                        "HIV_negative_Patients": "10"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Infections and infestations",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "5"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Infections and infestations",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "5"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Infections and infestations",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "5"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Infections and infestations",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "5"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Infections and infestations",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "5"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Infections and infestations",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "5"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Infections and infestations",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "5"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Infections and infestations",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "5"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Metabolism and nutrition disorders",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "4"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Metabolism and nutrition disorders",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "4"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Metabolism and nutrition disorders",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "4"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Metabolism and nutrition disorders",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "4"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Metabolism and nutrition disorders",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "4"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Metabolism and nutrition disorders",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "4"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Metabolism and nutrition disorders",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "4"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Metabolism and nutrition disorders",
                        "HIV_positive_Patients": "3",
                        "HIV_negative_Patients": "4"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Other",
                        "HIV_positive_Patients": "9",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "17.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Other",
                        "HIV_positive_Patients": "9",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Infections and infestations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "9",
                        "15.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Other",
                        "HIV_positive_Patients": "9",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Other",
                        "HIV_positive_Patients": "9",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Gastrointestinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "8",
                        "13.3%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Other",
                        "HIV_positive_Patients": "9",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "5",
                        "12.5%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Other",
                        "HIV_positive_Patients": "9",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Investigations",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "7",
                        "11.7%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Other",
                        "HIV_positive_Patients": "9",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-positive"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "4",
                        "10.0%"
                    ]
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Adverse_Event_SOC": "Other",
                        "HIV_positive_Patients": "9",
                        "HIV_negative_Patients": "13"
                    },
                    "measures": "[metric1, metric2, .., metric_i]",
                    "outcomes": "[outcome1, outcome2, .., outcome_i]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "trial": "REMoxTB",
                        "population": "matched population",
                        "phase": "enrolment",
                        "comparison": "HIV-positive vs HIV-negative patients",
                        "event severity": "Grade 3 or 4",
                        "event type": "Adverse Events (AEs)",
                        "filter": "five most frequently reported SOCs",
                        "system organ class (SOC)": "Respiratory, thoracic and mediastinal disorders",
                        "HIV status": "HIV-negative"
                    },
                    "measures": [
                        "Count",
                        "Percentage of G3+ Events"
                    ],
                    "outcomes": [
                        "6",
                        "10.0%"
                    ]
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 14,
        "total_ground_truth_claims": 10,
        "number_of_matches": 2
    },
    "PMC8391097_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "PrEP status": "Overall",
                        "HIV infections": "91",
                        "Total follow-up": "26 210",
                        "Incidence": "0.35",
                        "CI": "0.28-0.43",
                        "Citation": "0.35 (95% CI, 0.28-0.43) new infections per 100 person-years"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "HIV Incidence Rate Estimates",
                        "group": "Overall",
                        "HIV infections number": "91",
                        "Number of individuals": "13 861",
                        "total follow-up (person-years)": "26 210",
                        "incidence": "per 100 person-years",
                        "exclusion criteria": "Excludes individuals who were diagnosed with HIV during the eligibility assessment at PrEP linkage"
                    },
                    "measures": "[incidence rate, 95% CI]",
                    "outcomes": "[0.35 (0.28-0.43)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PrEP status": "Linked but not prescribed PrEP",
                        "HIV infections": "36",
                        "Total follow-up": "4119",
                        "Incidence": "0.87",
                        "CI": "0.63-1.21",
                        "Citation": "0.87 (95% CI, 0.63-1.21) among those not prescribed PrEP"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "HIV Incidence Rate Estimates",
                        "group": "Linked but not prescribed PrEP",
                        "HIV infection number": "36",
                        "Total number of individuals": "3013",
                        "total follow-up (person-years)": "4119",
                        "incidence": "per 100 person-years"
                    },
                    "measures": "[incidence rate, 95% CI]",
                    "outcomes": "[0.87, (0.63-1.21)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PrEP status": "Prescribed PrEP but did not initiate",
                        "HIV infections": "13",
                        "Total follow-up": "1226",
                        "Incidence": "1.06",
                        "CI": "0.62-1.83",
                        "Citation": "1.06 (95% CI, 0.62-1.83) among those prescribed but not initiated"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "HIV Incidence Rate Estimates",
                        "group": "Prescribed PrEP but did not initiate",
                        "HIV infection number": "11",
                        "Total number of individuals": "811",
                        "total follow-up (person-years)": "1226",
                        "incidence": "per 100 person-years"
                    },
                    "measures": "[incidence rate, 95% CI]",
                    "outcomes": "[1.06, (0.62-1.83)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PrEP status": "Discontinued but reinitiated PrEP",
                        "HIV infections": "4",
                        "Total follow-up": "1420",
                        "Incidence": "0.28",
                        "CI": "0.11-0.75",
                        "Citation": "0.28 (0.11-0.75) among those who discontinued and did not reinitiate PrEP"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "HIV Incidence Rate Estimates",
                        "group": "Discontinued but reinitiated PrEP",
                        "HIV infection number": "4",
                        "Total number of individuals": "1082",
                        "total follow-up (person-years)": "1420",
                        "incidence": "per 100 person-years"
                    },
                    "measures": "[incidence rate, 95% CI]",
                    "outcomes": "[0.28, (0.11-0.75)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PrEP status": "Discontinued and did not reinitiate PrEP",
                        "HIV infections": "38",
                        "Total follow-up": "2973",
                        "Incidence": "1.28",
                        "CI": "0.93-1.76",
                        "Citation": "1.28 (95% CI, 0.93-1.76) among those who discontinued and did not reinitiate PrEP"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "HIV Incidence Rate Estimates",
                        "group": "Discontinued and did not reinitiate PrEP",
                        "HIV infection number": "38",
                        "Total number of individuals": "2108",
                        "total follow-up (person-years)": "2973",
                        "incidence": "per 100 person-years"
                    },
                    "measures": "[incidence rate, 95% CI]",
                    "outcomes": "[1.28, (0.93-1.76)]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PrEP status": "Persistent on PrEP",
                        "HIV infections": "0",
                        "Total follow-up": "9139",
                        "Incidence": "0.00",
                        "CI": "0.00-0.04",
                        "Citation": "0.00 (0.00-0.04)<sup>c</sup>"
                    }
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "HIV Incidence Rate Estimates",
                        "group": "Persistent on PrEP",
                        "HIV infection number": "0",
                        "Total number of individuals": "5367",
                        "total follow-up(person-years)": "9139",
                        "incidence": "per 100 person-years",
                        "definition": "Persistent on PrEP refers to individuals who initiated and remained on PrEP throughout follow-up",
                        "confidence interval": "One-sided 97.5% upper CI"
                    },
                    "measures": "[incidence rate, 97.5% CI]",
                    "outcomes": "[0.00, (0.00-0.04)]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 10,
        "total_ground_truth_claims": 6,
        "number_of_matches": 6
    },
    "PMC8748440_2": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.0091",
                        "ISG15": "0.29",
                        "95% CI": "0.11-0.81"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.0091]",
                    "outcomes": "[0.29, 0.11-0.81]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "ISG15",
                        "module": "salmon Module 1",
                        "selection criteria": "p < 0.05"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.29, 0.11\u20130.81 0.0091]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.014",
                        "IFI6": "0.18",
                        "95% CI": "0.037-0.86"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.014]",
                    "outcomes": "[0.18, 0.037-0.86]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "IFI6",
                        "module": "salmon Module 1",
                        "selection criteria": "p < 0.05"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.18, 0.037\u20130.86, 0.014]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.083",
                        "IFI44L": "0.55",
                        "95% CI": "0.27-1.1"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.083]",
                    "outcomes": "[0.55, 0.27-1.1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "IFI44L",
                        "module": "salmon Module 1"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.55, 0.27\u20131.1, 0.083]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.045",
                        "IFI44": "0.23",
                        "95% CI": "0.047-1.2"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.045]",
                    "outcomes": "[0.23, 0.047-1.2]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "IFI44",
                        "module": "salmon Module 1",
                        "selection criteria": "p < 0.05"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.23, 0.047\u20131.2, 0.045]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.054",
                        "IFIT1": "0.37",
                        "95% CI": "0.12-1.1"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.054]",
                    "outcomes": "[0.37, 0.12-1.1]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "IFIT1",
                        "module": "salmon Module 1"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.37, 0.12\u20131.1, 0.054]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.15",
                        "OAS3": "0.52",
                        "95% CI": "0.22-1.3"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.15]",
                    "outcomes": "[0.52, 0.22-1.3]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "OAS3",
                        "module": "salmon Module 1"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.52, 0.22\u20131.3, 0.15]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.027",
                        "XAF1": "0.3",
                        "95% CI": "0.1-0.92"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.027]",
                    "outcomes": "[0.3, 0.1-0.92]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "XAF1",
                        "module": "salmon Module 1",
                        "selection criteria": "p < 0.05"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.3, 0.1\u20130.92, 0.027]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.023",
                        "TRIM25": "0.074",
                        "95% CI": "0.0068-0.8"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.023]",
                    "outcomes": "[0.074, 0.0068-0.8]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "TRIM25",
                        "module": "salmon Module 1",
                        "selection criteria": "p < 0.05"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.074, 0.0068\u20130.8, 0.023]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.074",
                        "CMPK2": "0.23",
                        "95% CI": "0.037-1.5"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.074]",
                    "outcomes": "[0.23, 0.037-1.5]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "CMPK2",
                        "module": "salmon Module 1"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.23, 0.037\u20131.5, 0.074]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.032",
                        "RSAD2": "0.2",
                        "95% CI": "0.041-0.99"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.032]",
                    "outcomes": "[0.2, 0.041-0.99]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "RSAD2",
                        "module": "salmon Module 1",
                        "selection criteria": "p < 0.05"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.2, 0.041\u20130.99, 0.032]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.42",
                        "EIF2AK2": "0.54",
                        "95% CI": "0.12-2.4"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.42]",
                    "outcomes": "[0.54, 0.12-2.4]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "EIF2AK2",
                        "module": "salmon Module 1"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.54, 0.12\u20132.4, 0.42]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.022",
                        "USP18": "0.23",
                        "95% CI": "0.062-0.84"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.022]",
                    "outcomes": "[0.23, 0.062-0.84]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "USP18",
                        "module": "salmon Module 1",
                        "selection criteria": "p < 0.05"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.23, 0.062\u20130.84, 0.022]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "study": "HIV",
                        "citations": "As a next step",
                        "module": "1",
                        "genes": "13",
                        "hub genes": "identified",
                        "WGCNA": "results",
                        "progression": "potentially",
                        "signature": "predict",
                        "viral suppression": "post-TI",
                        "HR": "Hazard Ratio",
                        "p value": "0.057",
                        "HERC6": "0.16",
                        "95% CI": "0.019-1.3"
                    },
                    "measures": "[study, HIV, citations, As a next step, module, 1, genes, 13, hub genes, identified, WGCNA, results, progression, potentially, signature, predict, viral suppression, post-TI, HR, Hazard Ratio, p value, 0.057]",
                    "outcomes": "[0.16, 0.019-1.3]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "analysis": "Univariable Cox regression for individual hub genes",
                        "gene": "HERC6",
                        "module": "salmon Module 1"
                    },
                    "measures": "[HR, 95% CI, p value]",
                    "outcomes": "[0.16, 0.019\u20131.3, 0.057]"
                },
                "match": "yes"
            }
        ],
        "total_extracted_claims": 13,
        "total_ground_truth_claims": 13,
        "number_of_matches": 13
    },
    "PMC7615197_2": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Citation": "116/263 (44.1%) observed deaths in the dexamethasone arm and 126/257 (49.0%) deaths in the placebo arm",
                        "HR": "0.85",
                        "CI": "0.66-1.10",
                        "P-value": "0.22"
                    },
                    "measures": "[Citation, MRC severity grade, Heterogeneity of effect]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Intention-to-treat population",
                        "Deaths (Dexamethasone)": "116/263",
                        "Deaths (Placebo)": "126/257",
                        "Method": "Cox proportional hazards model",
                        "Test for proportional hazards": "0.36"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value]",
                    "outcomes": "[0.85, 0.66-1.10, 0.22]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "I",
                        "Deaths (Dexamethasone)": "22/99",
                        "Deaths (Placebo)": "28/97",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.41-1.25, 0.24, 0.15, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "II",
                        "Deaths (Dexamethasone)": "60/125",
                        "Deaths (Placebo)": "68/126",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.82, 0.58-1.16, 0.27, 0.30, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Caption": "Analysis of primary outcome and pre-specified sub-groups in the intention-to-treat population"
                    },
                    "measures": "[Caption]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "I",
                        "Deaths (Dexamethasone)": "22/99",
                        "Deaths (Placebo)": "28/97",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.41-1.25, 0.24, 0.15, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "II",
                        "Deaths (Dexamethasone)": "60/125",
                        "Deaths (Placebo)": "68/126",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.82, 0.58-1.16, 0.27, 0.30, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Intention-to-treat population",
                        "Dexamethasone": "116/263",
                        "Placebo": "126/257",
                        "HR": "0.85 (0.66, 1.10); P=0.22"
                    },
                    "measures": "[Table 2, Intention-to-treat population]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade I",
                        "Dexamethasone": "22/99",
                        "Placebo": "28/97",
                        "HR": "0.72 (0.41, 1.25); P=0.24"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade I]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "I",
                        "Deaths (Dexamethasone)": "22/99",
                        "Deaths (Placebo)": "28/97",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.41-1.25, 0.24, 0.15, 0.63]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade II",
                        "Dexamethasone": "60/125",
                        "Placebo": "68/126",
                        "HR": "0.82 (0.58, 1.16); P=0.27"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade II]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "II",
                        "Deaths (Dexamethasone)": "60/125",
                        "Deaths (Placebo)": "68/126",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.82, 0.58-1.16, 0.27, 0.30, 0.63]"
                },
                "match": "yes"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Table 2": "Modified MRC grade: - Grade III",
                        "Dexamethasone": "34/39",
                        "Placebo": "30/34",
                        "HR": "1.11 (0.70, 1.77); P=0.65"
                    },
                    "measures": "[Table 2, Modified MRC grade: - Grade III]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Heterogeneity was tested by a Cox regression model that includes an interaction between treatment effect and subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Rationale for Leukotriene A4 hydrolase genotype sub-group provided in Supplementary Text S6"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Results are given for a sub-group with positive mycobacterial culture on baseline cerebrospinal fluid"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary endpoint was death from any cause over the first 12 months after randomization, i.e., time from randomization to death, over the first 12 months of follow-up"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "This table reports the results from the Cox proportional hazards regression model"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The primary effect measure was the resulting hazard ratio comparing dexamethasone vs. placebo with a corresponding two-sided 95% confidence interval"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In the \u2018Intention-to-treat population\u2019, treatment was the only covariate"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "We additionally report the hazard ratio with the modified MRC grade included as stratum variable"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for proportional hazards used the Kaplan-Meier as time transformation"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "In subgroup analyses, a separate Cox model was fitted for each value of the subgroup"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "The test for heterogeneity was based on the likelihood ratio test that includes subgroup as covariate and compares the models with subgroup as main effect only and with subgroup as treatment effect modifier, with TBM MRC severity grade at enrolment (I, II, or III) as covariates"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Modified MRC grade",
                        "Grade": "III",
                        "Deaths (Dexamethasone)": "34/39",
                        "Deaths (Placebo)": "30/34",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.03, 0.63-1.69, 0.90, 0.92, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Definite TBM",
                        "Deaths (Dexamethasone)": "48/108",
                        "Deaths (Placebo)": "49/104",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valu, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.90, 0.61-1.35, 0.62, 0.54, 0.63]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Probable TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.91, 0.64-1.30, 0.61, 0.17, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Diagnostic category",
                        "Category": "Possible TBM",
                        "Deaths (Dexamethasone)": "61/129",
                        "Deaths (Placebo)": "61/124",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.34, 0.66-1.63, 0.04, 0.08, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "TT",
                        "Deaths (Dexamethasone)": "12/25",
                        "Deaths (Placebo)": "11/26",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.06, 0.47-2.41, 0.88,0.17, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CT",
                        "Deaths (Dexamethasone)": "49/117",
                        "Deaths (Placebo)": "51/114",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.72, 0.49-1.05, 0.09, 0.25, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Leukotriene A4 hydrolase genotype",
                        "genotype": "CC",
                        "Deaths (Dexamethasone)": "38/84",
                        "Deaths (Placebo)": "36/80",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.04, 0.66-1.63, 0.88, 0.64, 0.40]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "MDR or rifampin mono-resistant",
                        "Deaths (Dexamethasone)": "7/10",
                        "Deaths (Placebo)": "5/6",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.66, 0.21-2.11, 0.48, 0.92, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "Isoniazid-resistant non-MDR",
                        "Deaths (Dexamethasone)": "6/14",
                        "Deaths (Placebo)": "13/20",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.56, 0.21-1.49, 0.25, 0.76, 0.37]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Anti-tuberculosis drug resistance",
                        "Drug resistance": "No or other resistance",
                        "Deaths (Dexamethasone)": "22/52",
                        "Deaths (Placebo)": "13/45",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.58, 0.79-3.13, 0.19, 0.37, 0.15]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "ART naive",
                        "Deaths (Dexamethasone)": "64/133",
                        "Deaths (Placebo)": "64/122",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.85, 0.60-1.21, 0.37, 0.20, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": ">3 months of ART",
                        "Deaths (Dexamethasone)": "20/46",
                        "Deaths (Placebo)": "26/58",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.54-1.72, 0.89, 0.83, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Art status on enrollment",
                        "Status": "Undetermined ART duration",
                        "Deaths (Dexamethasone)": "19/58",
                        "Deaths (Placebo)": "19/48",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.80, 0.42-1.51, 0.49, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "\u226450",
                        "Deaths (Dexamethasone)": "67/126",
                        "Deaths (Placebo)": "67/125",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P valueTest for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.96, 0.69-1.35, 0.87, 0.95, 0.91]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "51-100",
                        "Deaths (Dexamethasone)": "12/45",
                        "Deaths (Placebo)": "19/44",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.52, 0.23-1.06, 0.07, 0.22, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": "101-200",
                        "Deaths (Dexamethasone)": "14/36",
                        "Deaths (Placebo)": "13/35",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[1.24, 0.49-3.22, 0.65, 0.11, 0.41]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "ART=antiretroviral therapy. MRC=Medical Research Council. MDR=multi-drug resistant. TBM=tuberculous meningitis"
                    },
                    "measures": "[Footnote]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Subgroup": "Enrolment CD4 count (per mm3)",
                        "CD4 count": ">200",
                        "Deaths (Dexamethasone)": "11/37",
                        "Deaths (Placebo)": "15/36",
                        "Method": "Subgroup Cox model"
                    },
                    "measures": "[Hazard Ratio, 95% CI, P value, Test for proportional hazards, P-value for heterogeneity]",
                    "outcomes": "[0.70, 0.32-1.52, 0.36, 0.20, 0.41]"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 18,
        "total_ground_truth_claims": 20,
        "number_of_matches": 3
    },
    "PMC9008168_2": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Participants without HIV": "2144",
                        "Participants with BMI \u226525 kg/m\u00b2": "516",
                        "HIV status": "without HIV",
                        "ART status": "reference",
                        "Unadjusted incidence rate": "69.8",
                        "95% CI": "54.7-89.0"
                    },
                    "measures": "[HIV, without HIV]",
                    "outcomes": "[ART, reference]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on non-TLD ART",
                        "Person-time": "5069.11",
                        "Failures": "391",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[77.13, (69.85\u201385.17)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Participants without HIV": "2144",
                        "Participants with BMI \u226525 kg/m\u00b2": "516",
                        "HIV status": "without HIV",
                        "ART status": "reference",
                        "Unadjusted incidence rate": "69.8",
                        "95% CI": "54.7-89.0"
                    },
                    "measures": "[HIV, without HIV]",
                    "outcomes": "[ART, reference]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH, ART na\u00efve",
                        "Person-time": "503.77",
                        "Failures": "19",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[37.71, (24.06\u201359.13)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Participants without HIV": "2144",
                        "Participants with BMI \u226525 kg/m\u00b2": "516",
                        "HIV status": "without HIV",
                        "ART status": "reference",
                        "Unadjusted incidence rate": "69.8",
                        "95% CI": "54.7-89.0"
                    },
                    "measures": "[HIV, without HIV]",
                    "outcomes": "[ART, reference]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on TLD",
                        "Person-time": "559.35",
                        "Failures": "41",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[73.30, (53.97\u201399.55)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Participants without HIV": "2144",
                        "Participants with BMI \u226525 kg/m\u00b2": "516",
                        "HIV status": "without HIV",
                        "ART status": "reference",
                        "Unadjusted incidence rate": "69.8",
                        "95% CI": "54.7-89.0"
                    },
                    "measures": "[HIV, without HIV]",
                    "outcomes": "[ART, reference]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "People without HIV",
                        "Person-time": "937.23",
                        "Failures": "65",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[69.80, (54.74\u201389.01)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH on non-TLD ART": "77.1",
                        "95% CI": "0.79-1.63",
                        "HIV status": "PLWH",
                        "ART status": "non-TLD ART",
                        "HR": "1.13"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, non-TLD ART]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on non-TLD ART",
                        "Person-time": "5069.11",
                        "Failures": "391",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[77.13, (69.85\u201385.17)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH on non-TLD ART": "77.1",
                        "95% CI": "0.79-1.63",
                        "HIV status": "PLWH",
                        "ART status": "non-TLD ART",
                        "HR": "1.13"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, non-TLD ART]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH, ART na\u00efve",
                        "Person-time": "503.77",
                        "Failures": "19",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[37.71, (24.06\u201359.13)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH on non-TLD ART": "77.1",
                        "95% CI": "0.79-1.63",
                        "HIV status": "PLWH",
                        "ART status": "non-TLD ART",
                        "HR": "1.13"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, non-TLD ART]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on TLD",
                        "Person-time": "559.35",
                        "Failures": "41",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[73.30, (53.97\u201399.55)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH on non-TLD ART": "77.1",
                        "95% CI": "0.79-1.63",
                        "HIV status": "PLWH",
                        "ART status": "non-TLD ART",
                        "HR": "1.13"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, non-TLD ART]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "People without HIV",
                        "Person-time": "937.23",
                        "Failures": "65",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[69.80, (54.74\u201389.01)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH on TLD": "73.3",
                        "95% CI": "1.22-2.55",
                        "HIV status": "PLWH",
                        "ART status": "TLD",
                        "HR": "1.77"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, TLD]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on non-TLD ART",
                        "Person-time": "5069.11",
                        "Failures": "391",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[77.13, (69.85\u201385.17)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH on TLD": "73.3",
                        "95% CI": "1.22-2.55",
                        "HIV status": "PLWH",
                        "ART status": "TLD",
                        "HR": "1.77"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, TLD]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH, ART na\u00efve",
                        "Person-time": "503.77",
                        "Failures": "19",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[37.71, (24.06\u201359.13)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH on TLD": "73.3",
                        "95% CI": "1.22-2.55",
                        "HIV status": "PLWH",
                        "ART status": "TLD",
                        "HR": "1.77"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, TLD]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on TLD",
                        "Person-time": "559.35",
                        "Failures": "41",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[73.30, (53.97\u201399.55)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH on TLD": "73.3",
                        "95% CI": "1.22-2.55",
                        "HIV status": "PLWH",
                        "ART status": "TLD",
                        "HR": "1.77"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, TLD]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "People without HIV",
                        "Person-time": "937.23",
                        "Failures": "65",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[69.80, (54.74\u201389.01)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH": "ART na\u00efve, 37.7",
                        "95% CI": "0.27-0.70",
                        "HIV status": "PLWH",
                        "ART status": "ART na\u00efve",
                        "HR": "0.43"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, ART na\u00efve]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on non-TLD ART",
                        "Person-time": "5069.11",
                        "Failures": "391",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[77.13, (69.85\u201385.17)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH": "ART na\u00efve, 37.7",
                        "95% CI": "0.27-0.70",
                        "HIV status": "PLWH",
                        "ART status": "ART na\u00efve",
                        "HR": "0.43"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, ART na\u00efve]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH, ART na\u00efve",
                        "Person-time": "503.77",
                        "Failures": "19",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[37.71, (24.06\u201359.13)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH": "ART na\u00efve, 37.7",
                        "95% CI": "0.27-0.70",
                        "HIV status": "PLWH",
                        "ART status": "ART na\u00efve",
                        "HR": "0.43"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, ART na\u00efve]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on TLD",
                        "Person-time": "559.35",
                        "Failures": "41",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[73.30, (53.97\u201399.55)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "PLWH": "ART na\u00efve, 37.7",
                        "95% CI": "0.27-0.70",
                        "HIV status": "PLWH",
                        "ART status": "ART na\u00efve",
                        "HR": "0.43"
                    },
                    "measures": "[HIV, PLWH]",
                    "outcomes": "[ART, ART na\u00efve]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "People without HIV",
                        "Person-time": "937.23",
                        "Failures": "65",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[69.80, (54.74\u201389.01)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citation": "Of the 2144 participants at risk, 516 participants developed a BMI \u226525 kg/m\u00b2",
                        "Caption": "Unadjusted incidence rates and hazard ratios (HR) of BMI \u226525 kg/m\u00b2 by HIV and ART status"
                    },
                    "measures": "[Citation, Of the 2144 participants at risk, 516 participants developed a BMI \u226525 kg/m\u00b2]",
                    "outcomes": "[Caption, Unadjusted incidence rates and hazard ratios (HR) of BMI \u226525 kg/m\u00b2 by HIV and ART status]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on non-TLD ART",
                        "Person-time": "5069.11",
                        "Failures": "391",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[77.13, (69.85\u201385.17)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citation": "Of the 2144 participants at risk, 516 participants developed a BMI \u226525 kg/m\u00b2",
                        "Caption": "Unadjusted incidence rates and hazard ratios (HR) of BMI \u226525 kg/m\u00b2 by HIV and ART status"
                    },
                    "measures": "[Citation, Of the 2144 participants at risk, 516 participants developed a BMI \u226525 kg/m\u00b2]",
                    "outcomes": "[Caption, Unadjusted incidence rates and hazard ratios (HR) of BMI \u226525 kg/m\u00b2 by HIV and ART status]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH, ART na\u00efve",
                        "Person-time": "503.77",
                        "Failures": "19",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[37.71, (24.06\u201359.13)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citation": "Of the 2144 participants at risk, 516 participants developed a BMI \u226525 kg/m\u00b2",
                        "Caption": "Unadjusted incidence rates and hazard ratios (HR) of BMI \u226525 kg/m\u00b2 by HIV and ART status"
                    },
                    "measures": "[Citation, Of the 2144 participants at risk, 516 participants developed a BMI \u226525 kg/m\u00b2]",
                    "outcomes": "[Caption, Unadjusted incidence rates and hazard ratios (HR) of BMI \u226525 kg/m\u00b2 by HIV and ART status]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on TLD",
                        "Person-time": "559.35",
                        "Failures": "41",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[73.30, (53.97\u201399.55)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citation": "Of the 2144 participants at risk, 516 participants developed a BMI \u226525 kg/m\u00b2",
                        "Caption": "Unadjusted incidence rates and hazard ratios (HR) of BMI \u226525 kg/m\u00b2 by HIV and ART status"
                    },
                    "measures": "[Citation, Of the 2144 participants at risk, 516 participants developed a BMI \u226525 kg/m\u00b2]",
                    "outcomes": "[Caption, Unadjusted incidence rates and hazard ratios (HR) of BMI \u226525 kg/m\u00b2 by HIV and ART status]"
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "People without HIV",
                        "Person-time": "937.23",
                        "Failures": "65",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[69.80, (54.74\u201389.01)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Abbreviations: PLWH, people living with HIV; TLD, tenofovir/lamivudine/dolutegravir; PY, person-years"
                    },
                    "measures": "[Footnote, Abbreviations: PLWH, people living with HIV; TLD, tenofovir/lamivudine/dolutegravir; PY, person-years]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on non-TLD ART",
                        "Person-time": "5069.11",
                        "Failures": "391",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[77.13, (69.85\u201385.17)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Abbreviations: PLWH, people living with HIV; TLD, tenofovir/lamivudine/dolutegravir; PY, person-years"
                    },
                    "measures": "[Footnote, Abbreviations: PLWH, people living with HIV; TLD, tenofovir/lamivudine/dolutegravir; PY, person-years]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH, ART na\u00efve",
                        "Person-time": "503.77",
                        "Failures": "19",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[37.71, (24.06\u201359.13)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Abbreviations: PLWH, people living with HIV; TLD, tenofovir/lamivudine/dolutegravir; PY, person-years"
                    },
                    "measures": "[Footnote, Abbreviations: PLWH, people living with HIV; TLD, tenofovir/lamivudine/dolutegravir; PY, person-years]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "PLWH on TLD",
                        "Person-time": "559.35",
                        "Failures": "41",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[73.30, (53.97\u201399.55)]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Footnote": "Abbreviations: PLWH, people living with HIV; TLD, tenofovir/lamivudine/dolutegravir; PY, person-years"
                    },
                    "measures": "[Footnote, Abbreviations: PLWH, people living with HIV; TLD, tenofovir/lamivudine/dolutegravir; PY, person-years]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Group": "People without HIV",
                        "Person-time": "937.23",
                        "Failures": "65",
                        "Unadjusted incidence rate": "BMI \u226525 kg/m2"
                    },
                    "measures": "[Incidence rate per 100 person-years, (95% CI)]",
                    "outcomes": "[69.80, (54.74\u201389.01)]"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 6,
        "total_ground_truth_claims": 4,
        "number_of_matches": 0
    },
    "PMC7644038_3": {
        "matches": [
            {
                "Extracted_claim": {
                    "subject": {
                        "Citations": "People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV",
                        "Table": "Prevalence of health outcomes, unadjusted means and odds ratios reported",
                        "Footnotes": "Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests"
                    },
                    "measures": "[Citations, People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV, Table, Prevalence of health outcomes, unadjusted means and odds ratios reported, Footnotes, Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Health Outcome": "Depression",
                        "HIV Prevalence": "24.3%",
                        "No HIV Prevalence": "6.2%",
                        "Percent Difference": "291.9%",
                        "Method": "Logistic regression model (2016 data)"
                    },
                    "measures": "[Odds Ratio, 95% CI]",
                    "outcomes": "[2.29, 2.22-2.35]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citations": "People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV",
                        "Table": "Prevalence of health outcomes, unadjusted means and odds ratios reported",
                        "Footnotes": "Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests"
                    },
                    "measures": "[Citations, People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV, Table, Prevalence of health outcomes, unadjusted means and odds ratios reported, Footnotes, Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Health Outcome": "Chronic kidney disease",
                        "HIV Prevalence": "46.2%",
                        "No HIV Prevalence": "18.9%",
                        "Percent Difference": "144.4%",
                        "Method": "Logistic regression model (2016 data)"
                    },
                    "measures": "[Odds Ratio, 95% CI]",
                    "outcomes": "[1.92, 1.88-1.97]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citations": "People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV",
                        "Table": "Prevalence of health outcomes, unadjusted means and odds ratios reported",
                        "Footnotes": "Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests"
                    },
                    "measures": "[Citations, People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV, Table, Prevalence of health outcomes, unadjusted means and odds ratios reported, Footnotes, Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Health Outcome": "COPD",
                        "HIV Prevalence": "28.3%",
                        "No HIV Prevalence": "4.1%",
                        "Percent Difference": "590.2%",
                        "Method": "Logistic regression model (2016 data)"
                    },
                    "measures": "[Odds Ratio, 95% CI]",
                    "outcomes": "[1.52, 1.47-1.57]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citations": "People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV",
                        "Table": "Prevalence of health outcomes, unadjusted means and odds ratios reported",
                        "Footnotes": "Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests"
                    },
                    "measures": "[Citations, People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV, Table, Prevalence of health outcomes, unadjusted means and odds ratios reported, Footnotes, Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Health Outcome": "Osteoporosis",
                        "HIV Prevalence": "14.6%",
                        "No HIV Prevalence": "3.4%",
                        "Percent Difference": "329.4%",
                        "Method": "Logistic regression model (2016 data)"
                    },
                    "measures": "[Odds Ratio, 95% CI]",
                    "outcomes": "[2.17, 2.06-2.29]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citations": "People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV",
                        "Table": "Prevalence of health outcomes, unadjusted means and odds ratios reported",
                        "Footnotes": "Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests"
                    },
                    "measures": "[Citations, People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV, Table, Prevalence of health outcomes, unadjusted means and odds ratios reported, Footnotes, Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Health Outcome": "Colorectal cancer",
                        "HIV Prevalence": "3.8%",
                        "No HIV Prevalence": "1.3%",
                        "Percent Difference": "192.3%",
                        "Method": "Logistic regression model (2016 data)"
                    },
                    "measures": "[Odds Ratio, 95% CI]",
                    "outcomes": "[1.85, 1.70-2.03]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citations": "People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV",
                        "Table": "Prevalence of health outcomes, unadjusted means and odds ratios reported",
                        "Footnotes": "Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests"
                    },
                    "measures": "[Citations, People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV, Table, Prevalence of health outcomes, unadjusted means and odds ratios reported, Footnotes, Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Health Outcome": "Lung cancer",
                        "HIV Prevalence": "26.8%",
                        "No HIV Prevalence": "7.7%",
                        "Percent Difference": "248.1%",
                        "Method": "Logistic regression model (2016 data)"
                    },
                    "measures": "[Odds Ratio, 95% CI]",
                    "outcomes": "[1.38, 1.25-1.53]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citations": "People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV",
                        "Table": "Prevalence of health outcomes, unadjusted means and odds ratios reported",
                        "Footnotes": "Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests"
                    },
                    "measures": "[Citations, People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV, Table, Prevalence of health outcomes, unadjusted means and odds ratios reported, Footnotes, Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Health Outcome": "Hypertension",
                        "HIV Prevalence": "1.4%",
                        "No HIV Prevalence": "0.3%",
                        "Percent Difference": "366.7%",
                        "Method": "Logistic regression model (2016 data)"
                    },
                    "measures": "[Odds Ratio, 95% CI]",
                    "outcomes": "[1.31, 1.28-1.33]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citations": "People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV",
                        "Table": "Prevalence of health outcomes, unadjusted means and odds ratios reported",
                        "Footnotes": "Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests"
                    },
                    "measures": "[Citations, People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV, Table, Prevalence of health outcomes, unadjusted means and odds ratios reported, Footnotes, Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Health Outcome": "Ischemic heart disease",
                        "HIV Prevalence": "1.3%",
                        "No HIV Prevalence": "0.3%",
                        "Percent Difference": "333.3%",
                        "Method": "Logistic regression model (2016 data)"
                    },
                    "measures": "[Odds Ratio, 95% CI]",
                    "outcomes": "[1.31, 1.28-1.34]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citations": "People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV",
                        "Table": "Prevalence of health outcomes, unadjusted means and odds ratios reported",
                        "Footnotes": "Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests"
                    },
                    "measures": "[Citations, People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV, Table, Prevalence of health outcomes, unadjusted means and odds ratios reported, Footnotes, Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Health Outcome": "Diabetes",
                        "HIV Prevalence": "29.8%",
                        "No HIV Prevalence": "10.4%",
                        "Percent Difference": "186.5%",
                        "Method": "Logistic regression model (2016 data)"
                    },
                    "measures": "[Odds Ratio, 95% CI]",
                    "outcomes": "[1.06, 1.04-1.09]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citations": "People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV",
                        "Table": "Prevalence of health outcomes, unadjusted means and odds ratios reported",
                        "Footnotes": "Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests"
                    },
                    "measures": "[Citations, People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV, Table, Prevalence of health outcomes, unadjusted means and odds ratios reported, Footnotes, Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Health Outcome": "Chronic hepatitis",
                        "HIV Prevalence": "13.1%",
                        "No HIV Prevalence": "0.2%",
                        "Percent Difference": "6450.0%",
                        "Method": "Logistic regression model (2016 data)"
                    },
                    "measures": "[Odds Ratio, 95% CI]",
                    "outcomes": "[12.70, 11.86-13.59]"
                },
                "match": "no"
            },
            {
                "Extracted_claim": {
                    "subject": {
                        "Citations": "People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV",
                        "Table": "Prevalence of health outcomes, unadjusted means and odds ratios reported",
                        "Footnotes": "Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests"
                    },
                    "measures": "[Citations, People with HIV had higher overall unadjusted rates for all health conditions compared to those without diagnosed HIV, Table, Prevalence of health outcomes, unadjusted means and odds ratios reported, Footnotes, Each individual appears in this table once; in columns one through three it is at age 65, in column 4 it is in 2016 (in which upper age is trimmed at 98 years to avoid the impact of outliers who predominantly do not have HIV). Significance of the differences between (1) and (2) were calculated for each row using a chi-squared test. Not shown are controls for age, race/ethnicity, sex, state, rural/urban residence, and dual enrollment in Medicaid. The omitted group is White, urban, non-Medicaid enrolled males between the age of 65 and 74. Individuals are weighted using probability weights to reflect differential selection probabilities based on HIV diagnosis. 95% confidence intervals are reported in parentheses. Significance levels are shown with *** p-value<0.001, ** p-value < 0.01, and * p-value < 0.05. Each cell in (4) is a coefficient from a different model. Significance levels have been adjusted using the Bonferroni correction for multiple hypothesis testing to reflect 11 tests]",
                    "outcomes": ""
                },
                "Ground_truth_claim": {
                    "subject": {
                        "Health Outcome": "End-stage liver disease",
                        "HIV Prevalence": "2.7%",
                        "No HIV Prevalence": "0.1%",
                        "Percent Difference": "2600.0%",
                        "Method": "Logistic regression model (2016 data)"
                    },
                    "measures": "[Odds Ratio, 95% CI]",
                    "outcomes": "[4.51, 4.08-4.98]"
                },
                "match": "no"
            }
        ],
        "total_extracted_claims": 1,
        "total_ground_truth_claims": 11,
        "number_of_matches": 0
    }
}